The most advanced treatments for monkeypox were developed to address the wrong threat
- Oops!Something went wrong.Please try again later.
- Oops!Something went wrong.Please try again later.
- SIGA
- EBS
The markets may be in free fall, but a few biotechnology companies had an exceptionally good day. Siga’s stock is up more than 40%; Emergent Biosolutions’s gained nearly 12%, and Tonix Pharmaceuticals, 15%. A few cases of monkeypox have been registered in Europe and North America, far from West and Central Africa where outbreaks typically emerge.